Bright Angel Therapeutics
PrivateLast Round
Seed
Dec 3, 2019
Company Overview
Bright Angel Therapeutics is a biotechnology company that develops novel antifungal drugs to treat drug-resistant and life-threatening invasive fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bright Angel Therapeutics Comparables
Compare Bright Angel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rostra Therapeutics | 82% | |
| Brigid Bio Ltd | 78% | |
| Elion Therapeutics | 76% | |
Bright Angel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2019 | ||||
| Seed | Dec 21, 2017 |
Bright Angel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viva BioInnovator | Seed |
| Lumira Ventures | Seed |
| TIAP | Seed |
| adMare BioInnovations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors grew 70% MoM.
- Oct 30, 2024
Monthly visitors increased 139% MoM.
Bright Angel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bright Angel Therapeutics's valuation, stock price, and market status.